Table 1 Demographic and clinical characteristics at baseline
From: Effects of therapeutic plasma exchange on the endothelial glycocalyx in septic shock
Category | Median (IQR)/n (%) |
|---|---|
Age—year | 53 (34–59) |
Sex—no (%) | |
 Male | 16 (80) |
 Female | 4 (20) |
BMI—kg/m2 | 27.8 (21.9–32.6) |
Sepsis onset—no (%) | |
 Ambulatory | 14 (70) |
 Hospital acquired | 6 (30) |
Side of infection—no (%) | |
 Lung | 14 (70) |
 Abdomen | 3 (15) |
 Urogenital | 1 (5) |
 Soft tissue | 1 (5) |
 More than one | 1 (5) |
Identified pathogen—no (%) | |
 Gram+ | 3 (15) |
 Gram− | 6 (30) |
 Fungi | 1 (5) |
 Viral | 1 (5) |
 More than one | 2 (10) |
 Non-identified | 7 (35) |
SOFA | 18 (15–19) |
Norepinephrine dose (μg/kg/min) | 0.734 (0.564–1.206) |
CRP (mg/l) | 267 (151–325) |
PCT (μg/l) | 24 (9–99) |
Lactate (mmol/l) | 6.6 (2.6–11.3) |
Mechanical ventilation—no (%) | 18 (90) |
Oxygenation index (PaO2/FiO2) | 130 (117–189) |
Renal replacement therapy—no (%) | 13 (65) |